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ABSTRACT
FUNGAL GLYCOSPHINGOLIPIDS: CHARACTERIZATION OF STRUCTURES  
AND INTERACTIONS WITH PLANT DEFENSINS
by 
Jis Joe
University of New Hampshire, December, 2007
Glycosphingolipids (GSLs) play important roles in many fundamental 
biological processes like activation of signal transduction pathways, immune 
responses, and cell-cell interactions. Recent reports imply that fungal GSLs are 
important targets for the antifungal action of plant defensins. In order to study 
intermolecular interactions of GSLs, it is crucial to know their structures in detail. 
This thesis consists of two projects in which fungal GSLs of biological and 
biomedical significance are studied. In the first project, we have completed the 
structural characterization of acidic GSLs from S. cerevisiae using NMR 
spectroscopy and electrospray ionization mass spectrometry (ESI-MS). The 
second project of this thesis is carried out to help understand some of the 
possible interactions of fungal GSLs with plant defensins. Studies using enzyme 
-  linked immunosorbent assay and mass spectrometry are used to clarify some 
of the structural requirements for GSL -  defensin interactions. These in turn 
should lead to more general insights into structure -  function relationships of 
GSLs and proteins that bind to them.
x
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER I
INTRODUCTION
Fungi, plants and animals represent three well-known phylogenetic 
kingdoms within the eukaryotes (non-bacteria) having similar cellular, genomic 
and metabolic organizations. Fungi rank in importance with bacteria as agents in 
the biosphere for biochemical transformations and environmental housekeeping. 
Along with bacteria and viruses, fungi take part in number of complex 
interspecies interactions as either symbionts or pathogens. By breaking down 
dead organic material, they continue the cycling of nutrients through ecosystems. 
In addition, most vascular plants could not grow without the symbiotic fungi that 
inhabit their roots and supply essential nutrients. Other fungi provide numerous 
drugs (such as penicillin and other antibiotics), foods like mushrooms, truffles 
and morels, and the bubbles in bread, champagne, and beer. Fungi also cause a 
number of plant and animal diseases. Because fungi are more chemically and 
genetically similar to animals than other organisms, fungal diseases are very 
difficult to treat. However, due to these similarities a number of fungi are 
important model organisms for studying problems in cellular and molecular 
biology. Because of the many shared characteristics of eukaryotic cell 
membranes, fungi have been proposed as good model systems for the study of 
genetics, biosynthesis, organization and functional interactions of membrane 
components [1, 2, 3]. Among these key components are the sphingolipids,
1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
derivatives of sphingolipids, a family of functionalized long-chain alkyls with a 
defining 1, 3-dihydroxy-2-amino structural motif. The bulk of cellular sphingolipids 
are incorporated into fatty-N-acylated derivatives called ceramides. Ceramides, 
in turn, are further used as substrates for a variety of enzymes that catalyze the 
attachment of polar head groups, such as myo-inositol phosphate, choline 
phosphate, and monosaccharide residues. Attachment of the latter produces 
glycosphingolipids (GSLs).
Glycosphingolipids 
Glycosphingolipids are, together with sterols and glycerophospholipids the 
major types of lipids found in eukaryotic membranes. GSLs are one of the most 
abundant components of the fungal plasma membrane, with smaller amounts 
found in other cellular membranes. Despite their abundance, functional roles of 
GSLs and other sphingolipids in cellular processes have only begun to be 
elucidated in recent decades. While significant progress has been made, many 
specific functions of complex GSLs await elucidation. It has been proven that 
sphingolipids play important structural and regulatory roles in membranes [2, 3, 
4]. Ceramides, basic building blocks of sphingolipids, are reported to be signaling 
molecules in mammals. Exactly how ceramides activates signal transduction 
pathways is not well understood, but it is clear that the pathways control many 
cellular processes including apoptosis, proliferation and differentiation, immune 
responses, and cell-cell interactions. Established roles of the sphingolipids also 
include signaling functions during heat stress, mediating transport of glycosyl 
phosphatidylinositol (GPI)-anchored proteins from endoplasmic reticulum to
2
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Golgi, regulating calcium homeostasis, and interactions with sterols that are 
important for lipid raft formation and function [3, 4]. Interest has been sparked by 
indications that they play an important role in interactions with plant-derived small 
antimicrobial peptides, called defensins, which target fungal membrane 
components [5, 6]. The existence of high affinity binding sites for these defensins 
on fungal plasma membrane fractions has been demonstrated [7, 8, 9, 10]. 
Considerable evidence suggests that in most of the cases these binding sites are 
GSLs, or include GSLs as essential components.
Recent studied have shown that GSLs may be used for sensitive and 
reliable recognition of certain protein toxins like tetanus toxin and cholera toxin 
[11]. GSLs have been shown to undergo strong interactions with potential 
bioterrorism agents such as ricin and botulinum neurotoxin. Attempts have been 
made to develop biosensors using GSLs as the recognition molecules [21, 31]. 
Traditionally, antibodies have been used as detection molecules for these types 
of toxins. However, GSLs offer several potential advantages over antibodies, 
including increased stability under ambient conditions, ease of orientation at the 
sensor surface through hydrophobic/hydrophilic interactions, and a large number 
of binding sites per unit area compared to the larger antibody.
Disruptions in GSL biosynthetic pathways have been shown to inhibit 
growth and differentiation. Many studies have proven that GSL synthesis is 
essential for the organization of embryonic tissues. In some inherited pathologies 
the GSL biosynthetic pathway is intact, but the degradative pathways are not fully 
functional. This situation leads to a disease state due to inactive enzymes or
3
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activators needed for the metabolic degradation of biosynthetic products [13, 14]. 
Gaining a clearer understanding of GSL structure, biosynthesis, and function will 
help in treating diseases caused by GSL pathway defects in eukaryotes, as well' 
as diseases mediated by their use as microbial binding sites.
Biosynthetic pathway 
Synthesis and expression of sphingolipids seems to be essential for normal 
processes in fungal and animal cells. Many essential features of the biosynthetic 
pathways for GSL expression have been established in both animals and fungi. 
Early steps in both animal and fungal species are similar, but the predominant 
final products are structurally different. Fungal cells possess some exclusive 
pathways of sphingolipid biosynthesis, some of which are crucial to cell viability. 
For that reason, biosynthesis of sphingolipids is emerging as an attractive target 
for the action of antifungal drugs. Several inhibitors of sphingolipid synthesis in 
fungi, all natural products and most of them non-toxic to mammalian cells, have 
been in fact reported in the last decade [12, 15, 16]. This observation agrees 
with the fact that, between fungal and mammalian cells, glycosphingolipids differ 
in structure and biosynthesis. The understanding of GSL biosynthesis is, 
therefore, fundamental for the development of antifungal drugs and for the 
complete knowledge of lipid function in fungal cells.
All organisms begin sphingolipid synthesis by condensing serine and 
palmitoyl-CoA to yield 3-ketodihydrosphingosine (see Scheme 1-1). This 
essentially irreversible reaction is catalyzed by serine palmitoyltransferase (SPT). 
The genes believed to code for SPT activity is LCB1, LCB2, and TSC3. Deletion
4
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of either LCB1 or LCB2 is lethal to the organism. The product of TSC3 is 
necessary for optimal SPT activity, since its absence in vitro leads to reduction of 
SPT activity to a great extent. 3-ketodihydrosphingosine is reduced by an 
NADPH-requiring reaction yields the long-chain base dihydrosphingosine 
(sphinganine).The gene TSC10 has been shown to encode the enzyme, 3- 
ketodihydrosphingosine reductase, necessary for the formation of sphinganine in 
sphingolipid synthesis. Next, a fatty acid, generally between 16 and 26 carbons 
long, is then amide-linked to dihydrosphingosine to yield dihydroceramide. This 
reaction is catalyzed by dihydrosphingosine A/-acyltransferase (ceramide 
synthase) enzyme, whose activity is coded by two genes, LAG1 and LAC1. A 
deletion of either gene is not lethal to the organism, but the cells grow poorly. 
Hydroxylation of C4 of the dihydrosphingosine moiety of dihydroceramide yields a 
ceramide containing the long-chain base phytosphingosine. On the other hand, 
dehydrogenation at C 4 - C 5  produces a ceramide containing the long-chain base 
referred to as sphingosine. The SUR2ISYR2  gene is necessary for hydroxylation 
of dihydrosphingosine. In general, ceramides comprise a large, diverse family of 
N-acylated derivatives of sphingoids, where sphingoid is any long-chain 
hydrocarbon with a 2-amino-1,3-dihydroxy functional motif [2, 3, 4, 9]. Scheme 1- 
1 shows some of the important steps in biosynthetic pathway for the formation of 
ceramides. Glycosylation of ceramide, or a ceramide derivative called myo­
inositol phosphorylceramide (IPC), yields GSLs.
5
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Scheme 1-1: GSL biosynthetic pathway
Two general groups of GSLs are known in fungi and they are 
distinguished from each other by the relation of their carbohydrate to the
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ceramide moiety. While only a small number of fungi have been examined, most 
contain GSLs composed of ceramide derivatized at 0-1 with myo-inositol-1- 
phosphate (IPC). The myo-inositol is then glycosylated by the sequential action 
of glycosyltransferases, generally beginning at 0 -2  or 0 -6  of the inositol moiety. 
Typical glycosyl residues include mannose (Man), galactose (Gal), fucose (Fuc), 
and xylose (Xyl). These compounds are commonly called glycosylinositol 
phosphorylceramides (GIPCs) [18,19]. In general, GIPCs are not found in 
mammalian cells or tissues, but are characteristic GSL components of fungi and 
plants. Many studies have shown that GIPCs are essential for the survival of 
fungi [17]. A representative structure of a simple GIPC is given in Figure 1-1. A 
total of ~ 30 distinct GIPC structures have been identified to date, with the 





OH OH.0— P -OH
Figure1-1: Representative structure of GIPCs (a-mannosyl inositol 
phosphorylceramide)
Biosynthesis of fungal GIPCs starts with the transfer of myo-inositol-1- 
phosphate (IP) from the diacylglycerol (DAG) moiety of phosphatidylinositol to 
ceramide. This reaction is catalyzed by the AUR1 gene family-encoded enzyme
7
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IPC synthase. In many fungi, the common intermediate Ma2IPC is next 
synthesized by the action of an a 1,2-mannosyl transferase (Ma2-T). In 
Saccharomyces cerevisiae, this enzyme is encoded by either SUR1/CSG1 or 
CSG2, or both genes; next, the IPT1 encoded protein transfers a second myo- 
inositol-1-phosphate from phosphatidylinositol to Ma2IPC forming IP6Ma2IPC. In 
many other fungi, an as yet unknown Ma3-T transfers a second a-Man residue to 
Ma2IPC to make a common intermediate Ma3Ma2IPC [17]. Scheme 1-2 shows 
the structure and biosynthesis of some fungal GIPCs.
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The second major class of fungal GSLs is the monohexosylceramides, 
having either (3-glucose or (3-galactose attached directly to the ceramide to 
generate |3-glucosyl ceramide or p-galactosyl ceramide (GlcCer or GalCer, 
respectively). Fungal glycosylceramides are much conserved structures, in which 
modifications include different sites of unsaturation as well as the varying length 
of fatty acid residues in the ceramide moiety. They usually contain a ceramide 
moiety with 9-methyl-4,8-sphingadienine amide linked to 2-hydroxyoctadecanoic 
or 2-hydroxyhexadecanoic acids. Fungal glycosylceramides sometimes contain 
additional sugar residues, but are more commonly encountered as terminal 
products. These molecules are formed through the action of UDP-glycosyl 
ceramide glycosyltransferases (glycosylceramide synthases). Some fungi have 
been shown to produce both GlcCer and GalCer while others only produce 






Figure 1-2: Representative Structure of GSLs ((3-D-glucosylceramide)
Based on numerous studies, fungal cells are believed to have two different 
pools of ceramides to be used for the synthesis of different sphingolipids.
9
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Ceramide backbones with C16 or C18 a-hydroxy fatty acids linked to a 4, 8- 
diene-9-methyl-sphingoid, widely identified in several fungal species, are thought 
to be exclusively used as precursors of glycosylceramide synthesis. In contrast, 
ceramide backbones with relatively long chain C24 and C26 a-hydroxy fatty acids 
bound to phytosphingosine are thought to be restricted to the synthesis of the 
myo-inositol containing phosphosphingolipids [35].
On the other hand, in other eukaryotes, such as animal species,
GlcCer and GalCer are generally not accumulated, but further glycosylated to 
form a wide variety of complex GSLs. The great diversity of mammalian GSL 
glycans results in large part from mixing and matching the core structures with 
the peripheral and side-chain monosaccharide residues. Additional diversity in 
molecular species structure often derives from the occurrence of a distribution of 
multiple ceramide forms attached to each glycan in the GSL pool. In mammals 
GlcCer and GalCer are inherently important for a number of reasons. It has been 
suggested that glycosylation of ceramide can protect mammalian cells from 
cancer drug-induced apoptosis [1]. Accumulation of GlcCer was observed in 
another study of multidrug-resistant tumor cells [10]. These findings support the 
idea that ceramide may be a second messenger in stress responses and 
apoptosis.
Importance of Characterizing GSLs of Fungi 
Studies carried out during the 1990s demonstrated that many species of 
fungi are vulnerable to inhibitors of sphingoid biosynthesis. This has stimulated 
increased interest in the structure, biosynthesis, and functional roles of fungal
10
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sphingilipids. Fungal GSLs, as well as the cellular machinery regulating their 
expression are potential targets for the diagnosis and treatment of fungal 
diseases. This is important because of the dramatic increase in the frequency of 
severe mycotic infections and resistance to available antifungal agents during the 
past two decades. This situation has created an urgent need for new antifungal 
therapeutic and diagnostic agents, and by extension, an imperative to identify 
components that are not only critical to fungal life cycle and infectivity but that 
also contain structural elements distinct from those of the host. Since GIPCs 
generally are not synthesized by mammals, they represent promising targets for 
antifungal drug development. While the exact functions of GIPCs are still being 
studied, it appears GIPCs are an essential requirement for the survival of fungi. A 
particularly interesting target is the fungal IPC synthase, inhibitors of which are 
highly toxic to many mycopathogens but exhibit low toxicity in mammals [14,15]. 
IPC synthase catalyzes the transfer of myo-inositol-1-phosphate from 
phosphatidylinositol to ceramide. If further steps in the biosynthetic pathway of 
GIPCs are identified as essential, the enzymes catalyzing these reactions, 
glycosyltransferases, may also be potential targets of inhibitory drugs.
In the past, a number of studies have targeted fungal cell wall proteins, 
glycoproteins, and polysaccharide components as this has been thought to be 
the location for direct host-pathogen interaction [25, 27]. GSLs are known to have 
the potential to induce strong immunological responses in the host when they 
incorporate structural features different from those of the host [24]. Isolation and 
detailed characterization of GSLs from a variety of fungi has begun to reveal an
11
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extensive structural diversity, the expression of which is considerably dependent 
on species and at least in some mycopathogens, strongly regulated during 
morphogenesis. Antigenic glycoside determinants are expressed on some fungal 
GSL components, suggesting their potential as targets for immunodiagnostic 
reagents and the possibility of therapy based on stimulation of the mammalian 
humoral response. Elucidation of such immunological interactions calls for further 
detailed knowledge of the structures of these compounds, which is still limited 
compared with what is known about GSLs of animal species.
This thesis consists of two projects in which fungal glycosphingolipids 
(GSLs) of biological and biomedical significance are studied. The first project in 
this thesis, described in chapter 2, was aimed at completing the structural 
characterization of GSLs from the yeast species Saccharomyces cerevisiae. In 
this work, we completed characterization of two GIPCs from S. cerevisiae using 
one- and two-dimensional (1-D and 2-D) NMR spectroscopy and electrospray 
ionization mass spectrometry (ESI-MS).
The second project of this thesis, described in chapter 3, was carried out 
to help understand some of the possible interactions of fungal GSLs with plant 
defensins. Defensins are small peptides with conserved structural motifs 
expressed in species from all eukaryotic kingdoms. Many of these have 
antimicrobial activity, and several have strong antifungal activity [22, 24]. 
Structural determinants in plant defensins that govern their antifungal activity and 
the mechanisms by which they inhibit fungal growth remain unclear. Studies 
using enzyme -  linked immunosorbent assay (ELISA) and mass spectrometry
12
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were proposed to clarify some of the structural requirements for GSL -  defensin 
interactions. These in turn should lead to more general insights into structure -  
function relationships of GSLs and proteins that bind to them.
13
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CHAPTER II
STRUCTURE ELUCIDATION OF GLYCOSPHINGOLIPIDS FROM  
Saccharomyces cerevisiae
Introduction
The hemiascomycete fungus Saccharomyces cerevisiae (baker’s 
yeast) will likely be the first organism in which all genes necessary for 
sphingolipid metabolism are identified, although its repertoire is limited. Even 
though we have a fair understanding of the possible roles of sphingolipids in S. 
cerevisiae, the mechanisms at the molecular level leading to these functions are 
not clearly understood. S. cerevisiae only makes complex sphingolipids that 
contain myo-inositol. These are inositol-phosphorylceramide (IPC), mannose- 
inositol-phosphorylceramide (MIPC) and mannose-di-(inositol-phosphoryl)- 
ceramide (M(IP)2 C) [3, 4]. Although the polar headgroups of animal and fungal 
GSLs are fundamentally different, the pathways for ceramide biosynthesis have 
many common features, with key homologous genes shared between them. For 
this reason, S. cerevisiae, a widely used laboratory model, is considered relevant 
for unraveling the roles and molecular mechanism in signaling, membrane 
structure and functional interactions in all eukaryotes.
The three complex sphingolipids in Saccharomyces cerevisiae are located 
primarily in the plasma membrane where they account for 30% of plasma 
membrane phospholipids, which is about 7-8% of the total mass of the
14
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membrane. M(IP)2 C, the terminal sphingolipid, accounts for about 75% of the 
mass of total sphingolipids; the remainder are IPC and MIPC [2, 3, 4]. Because 
of their large mass and large negative charge they are likely to have general 
effects on processes that are dependent upon the plasma membrane. Whether 
these sphingolipids are concentrated in the inner leaflet or in the outer leaflet of 
the plasma membrane is not known.
IPC in S. cerevisiae is formed by addition of myo-inositol phosphate to 
ceramides, a reaction catalyzed by IPC synthase whose activity requires the 
AUR1 gene. Deletion or inhibition of IPC synthase is fatal for S. cerevisiae. IPC is 
mannosylated to yield MIPC, a reaction that requires the SUR1 and CSG2 
genes. The terminal step requires the IPT1 gene, which catalyzes the addition of 
inositol phosphate to MIPC to yield M(IP)2C [4]. Studies have shown that 
/PT7mutant cells lack M(IP)2C in their membrane and are drug-resistant. Such 
mutant cells are also resistant to an antifungal plant defensin produced by 
species of dahlia [9], Recently it was proven that this defensin-sensitivity is not 
linked with the presence of a nonfunctional IPT1-encoding protein but with the 
presence of M(IP)2C in the fungal plasma membrane [12]. Monohexosyl 
ceramides like GlcCer or GalCer have never been found in S. cerevisiae under 
various culture conditions. This is in contrast with many fungal and yeast species 
in which both inositolphosporyl-containing sphingolipids and significant amounts 
of glycosylceramides have been detected.
Recent reports imply that M(IP)2C is implicated in interactions with 
components of plant immune systems [26, 29]. The specific role of M(IP)2C in the
15
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antifungal action is an intriguing problem waiting to be solved. In order to study 
intermolecular interactions of S. cerevisiae GIPCs, it is crucial to know their 
structures in detail. While the ceramide structures are well known, detailed data 
precisely specifying the primary linkage sequence of the polar groups of MIPC 
and M(IP)2C have never been published. Preliminary studies suggest that the 
complex sphingolipids of S. cerevisiae, IPC, MIPC, and M(IP)2 C, are not 
monomolecular species, but each is a mixture differing in the chain length of both 
the long chain base and/or the fatty acid. To fully understand how sphingolipid 
metabolism is integrated with other cellular metabolism, and how these 
compounds contribute to the various cellular functions, these structural details 
need to be established.
Experimental Methods 
1 H- and 1 3C- Nuclear magnetic resonance spectroscopy (NMR)
Previously isolated and purified underivatized GIPC samples were obtained 
from Professor Robert L. Lester, University of Kentucky. They were deuterium 
exchanged by repeated lyophilization from D2 0 , and then dissolved in 0.5mL 
DMSO-c/6/2% D20  for NMR analysis. 1-D 1H NMR , 2-D 1 H-1H gradient 
enhanced correlation (gCOSY),1H-1H total correlation (TOCSY), and 1H - 1 3C- 
gradient enhanced heteronuclear single quantum coherence (gHSQC) 
experiments were performed at 35 °C on a Varian Unity Inova 500 MHz 
spectrometer using standard acquisition software available in the Varian VNMR  
software package.
16
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Positive ion mode ESI-MS analysis
Mass spectrometric analysis was performed on lipid samples using 
electrospray ionization mass spectrometry (ESI-MS) following lithium ion 
cationization [19]. For generation of [M(Li)2 +Li]+ and [M(Li)+Li]+ adductsof 
GIPC molecular species, lithium iodide (10mM) was added to the lipid samples 
dissolved in methanol until the observed ratio of [M(Li) +Li]+ adducts to mixed 
Na+/Li+ adducts in MS profile mode was >5:1(~ 4:1 in case of M(IP)2 C). The 
necessary Lil concentration was generally in the range of 3 to 5 mM. Mass 
spectrometry was performed on a Finnigan LTQ equipped with Advion Triversa 
Nanomate ESI chip in the positive ion mode with a spray voltage of 1.4 kV.
Results and Discussion 
NMR spectroscopic analysis of MIPC and M(IP)?C samples
In Figure 2-1 is reproduced the relevant downfield section of the1-D 1H- 
NMR spectrum of MIPC from S.cerevisiae. Previously published NMR data for an 
authentic Mana2IPC isolated under identical conditions from the mushroom A. 
blazei was used for comparison [15]. Signals with the same chemical shifts and 
splitting patterns are visible in the spectrum of MIPC from S.cerevisiae. The 
anomeric proton signal of MIPC was observed at 5.040 ppm versus 5.041 ppm 
previously observed in Mana2IPC. myo-inositol H-5 and H-3 signals were 
observed at 2.947ppm and 3.221 ppm, which in Mana2IPC were previously 
assigned at 2.956ppm and 3.222ppm respectively. Chemical shift/connectivity
17
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assignments of all 1H and 13C signals in the monosaccharide, inositol and the 
proximal part of the ceramide are performed by sequential application of 2-D 1 H- 
1H COSY, 1 H-1H TOCSY, and 1 H-13C gHSQC NMR experiments (spectra 
shown in Appendix A). The complete chemical shift assignments for MIPC from 
S.cerevisiae and A. blazei are listed for comparison in Table 2-1. All three 
residues in the S.cerevisiae compound were recognizable by their 
connectivity/coupling patterns. In particular, myo-inositol presents as a cyclic 1H 
spin system with all hydroxyl groups equatorial except that at C-2; therefore, all 
3-bond coupling constants between the non-exchangeable ring protons are in the 
range of ~9 -  12 Hz, except H -1/H -2 and H -2/H -3, which are ~ 1.5 -  2.5 Hz. 
The downfield shift increments observed for Ins H-1, H-2 and H-3 of S.cerevisiae 
MIPC, compared with the same resonances in IPC of A. fumigatus (A5 (H-1) = 
0.130ppm; A5 (H-2) = 0.168 ppm; A5 (H-3) = 0.019 ppm), correlates with a- 
mannosylation at Ins 0 -2  [17]. All other 1H and 13C chemical shifts are consistent 
with the Mana2IPC structure [15]. Thus, data obtained from NMR spectroscopy 
suggest that the structure of MIPC in S.cerevisiae is authentic Manal —>2lns1<— 
P-»1Cer. See Figure 2-2.
18
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Figure 2-1: Downfield section of 1-D 1 H-NMR spectrum of Ma2IPC. Low 
amplitude signals (<1H) between 4.1 and 4.8 ppm, and above 5.6ppm are 
incompletely exchanged hydroxyl protons.
Table 2-1
Comparison of 1H and 13C chemical shifts (ppm) for monosaccharide, inositol, 
ceramide sphingoid and fatty acyl (in parentheses) residues of Ma2IPC from S. 
cerevisiae and A. blazei in DMSO-c/6/2% D2 O at 308 K (35 °C)
S. cerevisiae A. blazei
Mancd--►2lns1<-P->1Cer Mana1->2lns1«-P--»1Cer
H-1 5.040 3.729 3.692 4.046 5.041 3.742 3.656 4.048
H-2 3.693 3.952 3.843 3.696 3.965 3.839
H-3 3.502 3.221 3.463 3.510. 3.222 3.470
H-4 3.473 3.326 3.367 3.468 3.341 3.360
H-5 3.851 2.947 3.851 2.956
H-6 3.448 3.483 3.487 3.487
H-6' 3.567 3.572
C-1 100.56 75.69 64.02 100.60 75.71 64.05
C-2 70.34 77.81 50.30 (71.07) 70.35 77.84 50.35 (71.13)
C-3 70.65 70.41 72.52 70.71 70.44 72.82
C-4 66.60 72.07 70.29 66.70 72.11 70.35
C-5 72.74 75.53 72.82 74.49
C-6 60.90 71.31 60.93 72.41
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Figure 2-2: Representative structure of MIPC (a-mannosyl inositol 
phosphorylceramide)
With the data from MIPC in hand, and using analogous NMR 
methodology, the structure of M(IP)2C was elucidated. The relevant downfield 
section of the 1-D 1 H-NMR spectrum of M(IP)2C is shown in Figure 2-3.
Complete assignments of relevant 1H and 13C resonances and connectivities 
were performed via 2-D spectroscopy. A relevant downfield section of the 2-D 1 H- 
1H TOCSY spectrum of M(IP)2C is given in Figure 2-4. Particularly, in the 2-D 
1 H-1H TOCSY spectrum of M(IP)2 C, two parallel cyclic spin systems 
corresponding to two inositol residues were clearly observed. The substantial 
downfield chemical shift increments of H- 6  and H-6 ’ of the Man residue in 
M(IP)2C (A5= +0.360 and +0.420 ppm respectively) indicates an electronegative 
substituent at the C - 6  position. This is consistent with a terminal inositol linked to 
C - 6  of Man via the PO3 group. From the observed shift of C - 6  (A5= +3.78 ppm) 
and of C-5 (A6 = -0.81 ppm) of the Man residue in M(IP)2C compared with 
spectral data for MIPC, it is evident that terminal inositol is linked to C - 6  of Man 
via the PO3 group. This is consistent with the inductive effect of substitution on a 
monosaccharide, which can affect the chemical shift of the linkage carbon by ~ 4 
ppm downfield (a- effect), and the adjacent carbon by ~1 ppm upfield ((3-effect).
20
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Based on these considerations the structure of M(IP)2C is established as Ins1+- 
P—► 6Ma1—>2lns1<— P—>1Cer from its NMR spectra. The chemical shift 
assignments for M(IP)2C are given in Table 2-2, along with the proposed 
structure (Figure 2-5).
The bulk CH2  resonance (1.234 ppm), representing the carbons between 
the terminal methyl groups and the functionalized groups, is difficult to integrate 
precisely. In any case, this represents a composite total for which there is no 
basis for assigning a specific distribution between the fatty acyl and sphingoid 
alkyl chains. Therefore these features for MIPC and M(IP)2C were further 




Mana H-1 Sph H-lb Ins H-i
Figure 2-3: Downfield section of 1-D 1 H-NMR spectrum of IP6Ma2IPC
21
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Figure 2-4: Downfield section of 2-D 1 H-1H TOCSY- NMR spectrum (200 msec 
mixing time) of IP6Ma2IPC in DMSO-d6/2% D 20  at 308 K (35 °C) showing 
strong inter residue correlations for two cyclic spin systems corresponding to two 
inositol residues along with mannose and the proximal part of ceramide spin 
systems.
22
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Table 2-2
1H and 13C chemical shifts (ppm) for inositols, monosaccharide, ceramide 
sphingoid and fatty acyl (in parentheses) residues of IP6Ma2IPC from S. 
cerevisiae, in DMSO-dy2%  D20  at 308 K (35 °C)
Ins1<— P—>6Mana1—>2lns1<—P—»1Cer
H-1 3.890 4.993 3.729 3.667 4.007
H-2 3.667 3.671 3.984 3.843
H-3 3.170 3.499 3.176 3.467
H-4 3.338 3.346 3.340 3.366
H-5 2.947 3.952 2.935
H-6 3.499 3.808 3.475
H-6' 3.987
C-1 75.71 100.57 75.90 64.09
C-2 71.78 70.38 77.78 50.31 71.10
C-3 71.37 70.41 70.60 72.42











Figure 2-5: Proposed structure of IP6Ma2IPC
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ESI-MS analysis of MIPC and M(IP)?C samples
Further characterizations, particularly of the ceramide moiety of the MIPC 
and M(IP)2 C samples, were carried out using electrospray ionization-linear ion 
trap mass spectrometry (ESI-LIT-MS). Nominal monoisotopic m/z values are 
used in the labeling and description of ESI-MS analysis. The major molecular ion 
species in the ESI-MS1 profile of the lithiated adducts for MIPC, [M(Li)+Li]+, were 
observed at m/z 1128 and 1156 (Figure 2-6). Selected MSn spectra from 
[M(Li)+Li]+ adducts are shown in Figures 2-7A and 2-7B (for m/z 1128), and in 
Figures 2-8A and 2-8B (for m/z 1156).
The two molecular adducts differ by m/z 28, corresponding to ceramide 
variants differing by 2 xCH2 from each other in either the fatty acyl or sphingoid 
components or both, m/z 1128 is consistent with a GIPC containing of one 
hexose, one inositol, and one phosphate residue bound to a t18:0/h26:0 or 
t20:0/h24:0 ceramide moiety. The former has been reported for GIPCs of S. 
cerevisiae (Ceramide III) [51, 52, 53]. MS2 analysis of the m/z 1128 molecular 
ion yielded ceramide related product ions at m/z 718 ([Cer + Li]+) and m/z 786 
( [CerP0 3 (Li) + Li]+ ) (Figure 2-7A). A less abundant fragment observed at m/z 
966 represents the residue [lns*P03 (Li)*Cer + Li]+ indicating loss of mannose 
from the m/z 1128 molecular ion. A pair of fragments observed at m/z 417 and 
435 are consistent with the residue formula ([Hex«lns*P«Li2]+). In MS3, m/z 718 
further fragments to m/z 291 and m/z 324, which are consistent with a 
t18:0/h26:0 ceramide moiety (Figure 2-7B).These fragments have been observed 
consistently in the product ion spectra of ceramides from GIPCs containing t18:0
24
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
sphingosine [19, 20]. The structure of the m/z 291 ion corresponding to t18:0 
sphingosine is shown in Figure 2-9. A fragmentation scheme for m/z 1128 of 
MIPC is shown in Scheme 2-1.
MS2 analysis of the molecular ion at m/z 1156 yielded ceramide related 
product ions at m/z 746 ( [Cer + Li]+) and 814 ( [CerP0 3 (Li) + Li]+), which have 
an increment of m/z 28 from m/z 718 and 786 respectively (Figure 2-8A). The 
residue [lns*PC>3 (Li)*Cer + Li]+) was observed at m/z 994 with an increment of 
m/z 28 from m/z 966. The ceramide related precursor ion at m/z 746 further 
fragments to m/z 319 and m/z 352 (Figure 2-8B), consistent with a t20:0/h26:0 
ceramide moiety. From the observed sequential fragmentation pattern it was 
concluded that the ceramide moieties in MIPC consist primarly of a fatty acyl 






Figure 2-6: ESI-MS1 Molecular profile of [M(Li)+Li]+ adducts of MIPC.
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Scheme 2-1: Characteristic fragmentations of the m/z 1128 of [M(Li)+Li]+ adduct 
of MIPC.
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Figure 2-7: MS2 and MS3 analysis of the [M(Li)+Li]+ adduct of MIPC m/z 1128 
(Panels A and B, respectively).
27




































i I i I I I I i 
500 550
m/z
i i i I ■ 
650
I - 1 
800
Figure 2-8: MS2 and MS3  analysis of the [M(Li) +Li]+ adduct of MIPC m/z 1156 
(Panels A and B, respectively).
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Figure 2-9: Structure of the sphingoid ion corresponding to m/z 291 from the 
t18:0 sphingosine - containing ceramide.
The major molecular ion species in the ESI-MS profile of the lithiated salt 
adducts for M(IP)2 C, [M(Li)2 +Li]+, were observed at m/z 1376 and 1404 (Figure 2- 
10). Fragmentation schemes of M(IP)2C are shown in Schemes 2-2A and 2-2 B. 
MSn spectra from selected [M(Li)2 +Li]+ adducts are shown in Figures 2-11 A, B 
and C (m/z 1376), and 2-12 A, B and C (m/z 1404).
The molecular ion observed at m/z 1376 is consistent with a GIPC 
consisting of one hexose, two inositol, and two phosphate residues bound to a 
t18:0/h26:0 or t20:0/h24:0 ceramide moiety. MS2 analysis of m/z 1376 yielded an 
abundant fragment at m/z 1128 for ([Hex*lns*P*Li2]+ + [Cer + Li]+) (Figure 2-11 A)
, which represents the loss of one terminal inositol with phosphate from 
[M(Li)2 +Li]+. A pair of less abundant fragments observed at m/z 1214 and 1196 
represents loss of terminal inositol from [M(Li)2 +Li]+. This spectrum also yielded a 
less abundant fragment at m/z 1034. The mass difference observed between m/z 
1196 and m/z 1034 is 162, which represents the loss of a hexose moiety only. 
This would be impossible without a rearrangement involving elimination of the
29
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Hex residue accompanied by migration of the second phosphate moiety to the 
charge -  retaining lns*P*Cer moiety. A possible fragmentation pathway would 
involve formation of an inter-residue cyclic phosphate bridge between Man 0 -6  
and an OH of Ins-1, concomitant with elimination of Ins-2. Elimination of the Man 
residue could then take place with formation of an intra -  residue cyclic 
phosphate of Ins-1. A proposed structure of such a cyclic phosphate product ion 
[P0 3 (Li)*lns»P0 3 (Li)*Cer + Li]+ is shown in Figure 2-13. From the MS3 analysis 
of the m/z 1128 precursor, ceramide related product ions were observed at m/z 
718 ([Cer + Li]+) and m/z 786 ([CerP0 3 (Li) + Li]+ ) (Figure 2-11B). The less 
abundant fragment observed at m/z 966 represents [lns»P03(l_i)*Cer + Li]+) 
indicating the loss of mannose from the m/z 1128 precursor as occurred with 
MIPC (Figure 2-7 A). A pair of fragments, observed at m/z 417 and 435 in this 
spectrum, is analogous to the fragments observed in MS2  analysis of [M(Li) +Li]+ 
from MIPC, consistent with the residue formula ([Hex»lns*P*Li2 ]+). In MS4, m/z 
718 further fragments to m/z 291 and m/z 324, which is consistent with a 
t18:0/h26:0 ceramide moiety (Figure 2-11C).
From the m/z 1404 molecular ion, further fragmentation yielded an 
abundant ion, m/z of 1156 ([Hex*lns*P*Li2 ]+ + [Cer + Li]+) (Figure 2-12A) which 
again represents the sequential loss of terminal inositol with phosphate from 
[M(Li)2 +Li]+. All fragments that include Cer are incremented by m/z 28 relative to 
the m/z 1376 precursor. Thus, fragments representing the loss of a terminal 
inositol from [M(Li)2 +Li]+ are observed at m/z 1224 and 1242, while the 
rearrangement leading to formation of the cyclic phosphate product
30
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[P0 3 (Li)*lns*P0 3 (Li)*Cer + Li]+ is observed at m/z 1062. Products of the m/z 
1156 intermediate precursor in MS3 included ceramide related product ions at 
m/z 746 ([Cer + Li]+) and 814 ([CerP0 3 (Li) + Li]+) (Figure 2-12B), which also 
have an increment of m/z 28 from m/z 718 and 786 respectively. The 
[lns*P0 3 (Li)*Cer + Li]+) fragment was observed at m/z 994. In MS4  analysis m/z 
746 further fragments to m/z 319 and m/z 352 (Figure 2-12C), consistent with a 
t20:0/h26:0 ceramide moiety. Therefore it was concluded that the predominant 
ceramide moieties in M(IP)2 C also have a fatty acyl chain of h26:0 and the 
sphingoids comprise a mixture of t18:0 and t2 0 : 0  phytosphingosines.
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Figure 2-10: ESI-MS1 Molecular profile of [M(Li)2 +Li]+ adducts for M(IP)2C
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Scheme 2-2: Characteristic fragmentations of the m/z 1376 of [M(Li)2 +Li]+ adduct 
of M(IP)2C
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Figure 2-11: MS2, MS3, and MS4  analysis of the [M(Li)2 +Li]+ adduct of M(IP)2 C 
m/z 1376 (Panels A, B, and C, respectively).
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Figure 2-12: MS2, MS3, and MS4  analysis of the [M(Li)2 +Li]+ adduct of M(IP)2 C 
m/z 1404 (Panels A, B, and C, respectively).
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Figure 2-13: Proposed structure of the m/z 1034 fragment formed by the 
migration of the second phosphate group to inositol accompanied by elimination 
of the Hex residue.
Besides the two major molecular salt adduct peaks at m/z 1376 and 
1404, other less abundant salt adducts are observed at m/z 1392 and 1420, with 
an increment of m/z 16 relative to the two major peaks. The shift of 16 amu is of 
interest, because it could be consistent with either an additional hydroxyl group 
on the ceramide or underlithiation, thus corresponding to mixed Na+/Li+ salt 
adducts. A good method to differentiate between these two possibilities is to 
perform MSn analysis on these +16 adducts, such as that observed at m/z 1392 
and compare with the fragmentation profile of m/z 1376 parent ion. Figure 2- 14A 
and B show the MS3 analysis of the precursors at m/z 1392 and 1376 
respectively. From the fragmentation pattern, it is clear that a difference of 16 
amu is observed between all of the ceramide related ions, which by itself might 
suggest that there is an extra hydroxyl group attached to the ceramide. However, 
the 16 amu shift can be observed, at least partially, in the glycosylinositol ions as 
well. An example is the ([Hex«lns»P»Li2]+) ions at m/z 435 and 417 from the m/z
35
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1376 parent ion (Figure 2-14B); these are partially shifted to m /z451 and 433 
when produced from the m/z 1392 parent ion [Figure 2-14A], Since there is no 
way for an extra hydroxyl group to be on the glycosylinositol, the 16 amu 
difference is attributed to underlithiation; that is, the m/z 1392 ion is the 



























Figure 2-14: MS3 analysis of M(IP)2C adducts of [M(Li)2 +Na]+ at m/z 1392 and 
M(Li)2 +Li]+ at m/z 1376.
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In the MS2 analysis of m/z 1376 and 1404, a common pair of fragments was 
observed at m/z 665 and m/z 683. These two fragments were further analyzed to 
confirm their identity, and found to be consistent with a fragment consisting of 
one hexose, two inositol, and two phosphate groups. Sequential analysis of 
these two fragments again confirmed the arrangement of residues in the polar 
head group of M(IP)2 C as IP-M-IP-C. The MSn anlysis of m/z 683 is shown in 
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Figure 2-15: MS3 and MS4  analysis of the m/z 683 fragment from M(IP)2 C 
(Panels A and B, respectively).
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Fragmentation of m/z 683 resulted in a pair of fragments at m/z 417 and 
435, which are consistent with the residue formula ([lns*P»Hex*Li2 ]+), after losing 
one inositol with a phosphate group (Figure 2-15A). A pair of fragments 
observed at m/z 503 and 521 represents loss of inositol without a phosphate 
group from m/z 683. Further analysis of m/z 435 yielded a pair of fragments at 
m/z 255 and 273 (Figure 2-15B), following the loss of a hexose, and is consistent 
with a residue formula of ([lns*P*Li2]+). The fragment at m/z 331 represents the 
non-phosphorylated glycan [Hex*lns + Li]+. The characteristic fragmentation of 





















Scheme 2-3: Proposed fragmentation scheme for m/z 683 of molecular precursor 
[M(Li)2 +Li]+ at m/z 1376
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Interpretation of the major ions from the MSn analysis of MIPC and M(IP)2 C 
is summarized in Table 2-3 and Table 2-4 respectively.
Table 2-3
Interpretation of the major ions from the MSn analysis of MIPC
m/z Fragment corresponds to
[M (L i)+Li]+
([Cer + L i] )+ 
([C erP03(Li) + Li])+
t l8 :0  phytosphingosine
[M (Li)2+L i]+
([Cer + L i] )+ 
([C erP03(Li) + Li])+
t20:0 phytosphingosine
Table 2-4
Interpretation of the major ions from the MSn analysis of M(IP)2C
m/z Fragment corresponds to
" [M (Li)2+Li]+
([Hex • Ins • P • L i2]+ + Cer) 
([Cer + L i] )+ 
([C erP03(Li) + L i])+
t!8 :0  phytosphingosine
[M (Li)2+L i]+
([Hex • Ins • P • L i2]+ + Cer) 
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With respect to glycosylinositol fragmentation, mainly glycosidic 
cleavages are observed, with possibilities of bond breakage on either side of the 
glycosidic oxygen, Li+ retention on either the reducing or the non-reducing portion 
of the glycan, along with retention or loss of lithium phosphate [30]. The 
persistence of sets of ions retaining the phosphate provides useful information in 
structural characterization. The results presented here clearly establish the 
linkages of the polar groups of MIPC, and M(IP)2 C of S. cerevisiae as 
M anat—>2lns1 <—P->1 Cer and Ins1 <— P—>6Mana1 —>2lns1 <-P-+1 Cer 
respectively. It is also evident that the ceramide moieties in MIPC and M(IP)2C 
have a fatty acyl chain of h26:0 and the sphingoid is a mixture of t18:0 and t20:0 
phytosphingosines. Results in this study could be a preliminary step towards 
analyzing the possible functional significance of such structures in this or other 
fungi. In attempts to correlate putative genes with specific glycosyltransferase 
activities and their possible cellular functions, or to study potential intermolecular 
interactions of fungal GSLs with host immune system components, precise 
knowledge of core linkages in fungal GIPCs will be an important consideration.
40
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CHAPTER III
INTERACTIONS OF GLYCOSPHINGOLIPIDS WITH PLANT DEFENSINS
Introduction
The basis of the interaction between an antigen and antibody lies in the 
complimentary shape of each molecule in the vicinity of their binding sites. The 
highly specific nature of these interactions, arises through the contact of the 
molecular surfaces of antigen and antibody that constitute an epitope and 
paratope, respectively. Water is generally excluded from the binding sites, and 
antigen-antibody complexes are stabilized through electrostatic interactions, 
hydrogen bonding, hydrophobic and Van der Waals forces. Antigen-antibody 
complexes are among the strongest non-covalent complexes known [47]. The 
formation of these macromolecular complexes plays an essential role in immune 
function.
One of the important regulatory roles of glycolipids is activating various 
signal transduction pathways that control many cellular processes, including 
immune responses [1]. Foreign GSLs can be recognized as antigens by the 
immune system. Some GSLs carry mammalian blood group determinants, and 
they can be strongly immunogenic when associated with foreign proteins or with 
other cell membrane components. GSLs from fungi, eukaryotic parasites, and 
sphingosine -  synthesizing prokaryotes are also recognized by mammalian host 
immune systems. A number of glycolipids play a role as tumor- associated
41
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antigens and in the immunotherapy of individual cancer forms [36, 37]. Many 
microbes have selected carbohydrates as a means of colonization and infection 
on the surface of mammalian cells. Considerable evidence suggests that in most 
of the cases these binding sites are GSLs, or include GSLs as essential 
components. Over the past 15-20 years, interest has been sparked by indications 
that the GSLs play an important role in interactions with plant-derived small 
antimicrobial peptides called defensins, which target fungal membrane 
components. The existence of high affinity binding sites for these defensins on 
fungal plasma membrane fractions has been demonstrated [22].
Plant Defensins
Plants depend on innate immune systems to defend themselves against 
potentially infectious pathogens that grow epiphytically on their surfaces. No 
acquired immune system is known for plants, and they lack a circulatory system. 
However, large repertoires of immune receptors that mediate local responses 
help trigger systemic defenses, effectively protecting plants from pathogen 
invasion. In the innate immune response, only one class of peptide seems to be 
conserved between plants, invertebrates and vertebrates, namely defensins. 
Defensins are small (45-54 amino acids) highly basic, cysteine-rich peptides 
expressed in species from all eukaryotic kingdoms including insects and humans 
[22, 24]. Up to now, three types of defensins have been identified in mammals; a- 
and j3- defensins, which occur generally, and 0-defensins, which have only been 
discovered in macaques. The plant defensin family is quite diverse regarding 
amino acid composition, but all plant defensins identified so far have eight
42
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cysteines that form four structure-stabilizing disulfide bridges. Based on the 
overall three-dimensional structure, there is a closer relationship between plant 
defensins, insect defensins and mammalian /3-defensins than between 
mammalian a- and jS- defensins [22]. This suggests that defensins are ancient 
peptides conserved across the eukaryotic kingdom, originating before the 
evolutionary divergence of plants and animals. Possibly, defensins have evolved 
from a single precursor, being a molecule with an overall structure resembling 
that of plant defensins. Three-dimensional.structures of defensins of various 
origins and the amino acid sequences of a mature plant defensins, RsAFPI and 
RsAFP2, from radish seed are shown in Figure 3-1A and B respectively.
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Figure 3-1: A. Three-dimensional structures of defensins of plant, invertebrate 
(insect and mollusc) and vertebrate (mammalian) origin. Structures were 
downloaded from the protein data bank (http://www.rcsb.org/pdb. B. Amino acid 
sequence of mature Rs-AFP1 and 2. Dashes indicate identical amino acid 
residues. Connecting lines between cysteine residues represent disulfide bonds 
and the spiral and arrows indicate the location of a- helix and p strands, 
respectively.
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Most plant defensins isolated to date exhibit antimicrobial activity, and 
several have strong antifungal activity against a broad range of species.
Structural determinants in plant defensins that govern their antifungal activity, 
and the mechanisms by which they inhibit fungal growth, remain unclear. A 
number of studies have attempted to unravel the mode of action of plant 
defensins. Based on the available evidence researchers have proposed a two- 
step model. This model suggests that the first step in the path leading to fungal 
growth inhibition would be binding of the plant defensins to specific sites on the 
plasma membrane of fungal hyphae. Interaction with these binding sites 
subsequently would enable plant defensins to insert into the plasma membrane, 
thus affecting membrane structure and permeability to certain solutes, such as 
Ca2+ and K+, some of which play an important role in fungal growth and 
development. This theory also suggests that once into the interior of the cell, the 
defensins affect protein synthesis and target other cytoplasmic components like 
RNA and DNA [24, 25]. These effects combined or alone would lead to fungal 
growth inhibition and cell death. It has been shown that GSLs are the specific 
binding sites for plant defensins in the fungal cell membrane, in some cases 
M(IP)2 C, and in others GlcCer [26].
Interestingly, several plant defensins are active against human fungal 
pathogens such as C. albicans [29, 30]. So far, none of the plant defensins has 
been found to cause detrimental effects on cultured human or plant cells. Several 
experiments point towards a role of defensins in defending the host from fungal 
attack [25]. The selective activity of plant defensins against fungal cells is most
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likely a result of differences at the level of the plasma membrane between fungi 
and plant cells. It has been shown, however, that some interact specifically with 
GSLs in the fungal cell membrane. Structural differences in these membrane 
components between fungal and plant cells may in part account for the non-toxic 
properties of plant defensins for plant cells.
Fungal GlcCer show a number of structural features that distinguish them 
from those found in mammals and plants. In most fungal species, GlcCer is 
composed primarily of a 9-methyl-4,8-sphlngadienine which is linked to a C16 or 
C18 a-hydroxy fatty acid [35]. GlcCer of mammalian origin usually have 
nonhydroxylated fatty acids. While the fatty acid in yeast GlcCer is mostly 
saturated, the fatty acids in GlcCer from filamentous fungi can be A3  -  
unsaturated to varying extents, with the proportion of unsaturation depending on 
species, strain, morphology, and culture conditions [32]. In plants, GlcCer 
structures are diverse. So far the main difference between fungal and plant 
GlcCer appears to be the addition of a branching 9-methyl group to the fungal 
sphingadienine base and complete lack of A3 -  unsaturation in the plant fatty acid 
moiety [35]. The effects of these structural differences in binding specificity will 
be discussed in detail later in this chapter.
This chapter of the thesis describes experiments performed to study the 
possible interactions of fungal GSLs with plant defensins. Although it was 
originally intended to study the putative interactions of M(IP)2 C with a defensin 
from radish (RsAFPI or RsAFP2) these have recently become unavailable. 
Therefore, another model system has been used, employing a defensin (M sDefl)
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from alfalfa (Medicago sativa), which has been proposed to interact with GlcCer 
from the fungus Fusarium graminearum, the agent of head blight disease in 
cereals [38, 39]. GlcCer variants from the crude neutral lipids of several fungi 
whose structures have been established previously [32, 33, 34, 35] as identical to 
that of F. graminearum, or contain known structural variations, were obtained and 
purified. These were employed in interaction studies with M sD efl. GlcCer of 
plant origin (extracted and purified from soy beans) and mammalian GlcCer and 
GalCer were used as further controls in these studies. The purpose here was to 
determine the potential significance of structural variations of both sugars and 
ceramides, in order to elucidate the specificity and sites of binding interaction. In 
this project a number of different experimental approaches were used to study 
the potential interactions of GSLs with plant defensins. Two traditional 
immunochemistry methods (TLC immunostaining and ELISA assays) were 
employed, and the results are discussed. A preliminary attempt to detect an 
MsDefl -  GlcCer complex by mass spectrometry was also carried out. There are 
many precedents for characterization of non-covalent complexes by mass 
spectrometry, but this is still controversial, and it is a challenge to prove 
specificity [47]. The main challenge is to ionize and transfer potentially fragile 
complexes from solution or solid into the gas phase, and particular attention has 
to be paid to understand and control the variety of processes involved. Matrix-  
assisted laser desorption ionization (MALDI) MS of proteins produces 
predominantly singly charged ions, which are within the normal range of 
detection of the time-of-flight (TOF) analyzer. However, the energies used for
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desorption may be unsuitable for maintaining a non-covalent complex. In 
contrast, the energies used in electrospray ionization (ESI) are much lower. 
Proteins and their complexes are generally larger than the normal mass range of 
the analyzers employed, but ESI-MS produces multiply charged ions, thereby 
bringing large molecular ions in to the m/z range of commercial mass 
spectrometers that are not able to detect their singly charged counterparts. 
Attempts to use both types of MS modes are described in this chapter.
Experimental Methods 
Solvents for extraction, high performance thin layer chromatography, silica gel 
and latro beads column chromatography.
All solvents used were of highest grade available (HPLC grade). Milli-Q 
water was used for solvent preparation. Solvent A, chloroform/methanol (1:1 v/v); 
Solvent B, isopropanol/hexane/water (55:25:20 v/v); Solvent C, 
chloroform/methanol/water (30:60:8 v/v/v); Solvent D, isopropanol/hexane/water 
(55:40:5 v/v/v); Solvent E, chloroform/methanol/water (60:35:8 v/v/v); Solvent F, 
chloroform/methanol (95:5 v/v); Solvent G, chloroform/methanol (9:1 v/v); 
Solvent H, chloroform methanol (8:2 v/v).
Extraction and fractionation of neutral qlvcosphinqolipids
Fungal growth and isolation were performed according to the standard 
protocol available in the laboratory. Extraction and purification of 
glycosphingolipids were carried out as described previously with some 
modifications and additional steps [34, 35]. Briefly, GSLs were extracted by
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homogenizing mycelia (25-35 g) in a glass walled blender, once with 200 ml_ of 
solvent A, two times with 200 ml_ of solvent B and once more with 200 mL of 
solvent A. The four extracts were pooled and dried on a rotary evaporator at 40 
°C. The dried residue was partitioned between water and 1-butanol pre-saturated 
with water (200 mL each) with vigorous shaking in a separatory funnel. The lower 
(water) layer was discarded, and similarly extracted 3 more times with equal 
volumes of water-saturated 1-butanol. The four 1-butanol extracts were 
combined in a round-bottom flask and evaporated to dryness. These samples 
were then transferred to 16x100 screw cap test tubes, conserving all material 
and treated with 20 mL methanol-water-1 -butanol (4:3:1 v/v/v ) containing 25- 
30% methylamine at 55 °C for 4 hours on a rocking platform. The lipids were 
dried under N2  stream at 35-40 °C and re-suspended in solvent C. The crude 
lipids were separated in to neutral and acidic fractions using a DEAE-Sephadex 
A-25 (weak anion exchanger) column. Neutral lipids were eluted with five bed 
volumes of solvent C, dried and taken up in 1 mL of solvent D. High performance 
thin layer chromatography (HPTLC) was then performed on the neutral fraction. 
High Performance Thin Laver Chromatography (HPTLC)
TLC analysis was performed on silica gel 60 pre-coated HPTLC plates 
(E.Merck, Darmstadt, Germany). The crude lipid samples dissolved in solvent D 
were applied to the plate by streaking frornlO pL microcaps. Analytical TLC was 
performed using solvent E as the mobile phase. Detection was made by Bial’s 
orcinol reagent (orcinol 0.55% [w/v] and H2 SO4  5.5% [v/v] in ethanol/water
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9:1 [v/v]; the plate is sprayed and heated briefly to 200-250 °C; violet/purple 
staining is positive for the presence of hexose).
Column Chromatography (silica qel-60)
Glucosylceramides from the crude lipids were separated by column 
chromatography using silica gel (Merck, 70-230 mesh, 60 A) as the stationary 
phase. A 2 x 25 cm glass column, with a 250 mL solvent reservoir, was packed 
with silica gel slurry prepared in a 95:5 v/v chloroform/methanol solvent mixture. 
The crude lipid sample was applied to the column and five bed volumes each of 
three solvent systems (F, G, and H) were used as mobile phase.
Column Chromatography (latro beads)
Glucosylceramides partially separated by the silica gel column were 
further purified by column chromatography using latro beads (6RS-8010; latron 
Chemical Laboratory, Tokyo, Japan) as stationary phase. A 2 x 25 cm glass 
column, with 250 mL solvent reservoir, was packed with a slurry of latrobeads 
prepared in a 95:5 v/v chloroform/methanol solvent mixtures. The lipid fraction 
eluted with solvent G from the silica gel column (lane 2 of silica gel column 
profile) was loaded onto the latro beads column and five bed volumes each of 
four mobile phase solvent systems (100% chloroform, solvents F, G, and H) were 
used.
TLC- overlay staining with anti-GlcCer
Glycolipids were spotted on silica-60 TLC plates with plastic support (two 
identical sets) and developed with a solvent system of chloroform: methanol: 
water (60:35:8, v/v/v). One set was visualized by spraying with orcinol and
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heating to 200-250 °C. For immunostaining, the region of the plate where GSLs 
are located was cut as a strip comparing with the visualized duplicate, so that the 
spots would correspond in position to those on the orcinol stained duplicate. This 
strip was incubated with blocking buffer ( 1 % polyvinylpyrrolidone and 0 .1 % 
nonfat dry milk in 50mM Tris-HCI, pH 7.4, 200 mM NaCI) for 1 hour at room 
temperature. After removing the excess blocking buffer, the plate was incubated 
with rabbit antiserum against GlcCer (GlycoTech, Germany) at a dilution of 1:200 
(in blocking buffer) overnight at room temperature. After five washings (5 min 
each with 20 mL) in washing buffer ( 50 mM Tris-HCI, pH 7.4, 200 mM NaCI), the 
plate was incubated with peroxidase -  conjugated goat anti-rabbit 
immunoglobulin(lg)G ( purchased from Dianova, Hamburg, Germany) diluted 
1:1000 in blocking buffer for 2 hours at room temperature. The plate was washed 
four times as before, and a fifth time in the substrate buffer (0.1 M sodium citrate, 
pH 4.5). Bound antibody was then detected by incubation with substrate solution 
(10 mL) which was freshly prepared and composed of 8.33mL substrate buffer,
1.67 mL of 4-chloro-1 -naphthol (3mg/mL in methanol) and hydrogen peroxide 
(3.5 pL of a 30% solution).
TLC- overlay with plant defensin (M sD efl)
Above described procedure was followed with few modifications. The 
initial steps were carried out without any significant changes. After the removal of 
excess blocking buffer, the plate was incubated with plant defensin (M sD efl, 85 
pM) at a dilution of 1:10(in blocking buffer), overnight at room temperature. As 
before, after five washings in washing buffer, the plate was incubated with anti-
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MsDefl antibody (200 |j M ) diluted 1:100 in blocking buffer for 2 hours at room 
temperature. The plate was then washed and incubated with peroxidase -  
conjugated goat anti-rabbit immunoglobulin (Ig) G diluted 1:1000 in blocking 
buffer for 2  hours at room temperature and detected by incubation with freshly 
prepared substrate solution.
Enzvme-Linked ImmunoSorbent Assay (ELISA)
PolySorp 96-well microtiter plates (Nalge Nunc International, Denmark) 
were used for the assay. Different GSLs were dissolved and serially diluted in 
methanol. Approximately 1 pg of GSL was used in the first well of each ELISA 
assay. Wells of the plate were coated with GSLs in methanol and dried under a 
hood. Unless stated otherwise 50 pL volumes were used. Any non specific 
binding sites on the wells were blocked with 200 pL of 10 mM phosphate 
buffered saline (PBS) supplemented with 1% bovine serum albumin (BSA) for 2 
hours at room temperature. Two different antifungal plant defensins were used 
for the study; MsDefl and MtDef4. After removing excess blocking solution by 
inverting the plate on paper towels, the wells were incubated with appropriate 
dilutions of plant defensins in blocking solution (MsDefl, 85 pM, diluted to 1:10 
and MtDef4, 200 pM, diluted to 1:20) overnight at 4 °C. After 3 washings in PBS 
(10mM) the wells were incubated with the appropriate anti-defensin antibody 
diluted in blocking solution for 2 hours at room temperature. The plate was 
washed 3 times in PBS (10mM) and peroxidase -  conjugated goat anti-rabbit 
immunoglobulin(lg)G ( purchased from Dianova, Hamburg, Germany) diluted 
1 : 1 0 0 0  in blocking buffer was added and incubation was continued for 2  hours at
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room temperature. After the plate was washed in PBS (3 times), the plate was 
incubated with freshly prepared substrate solution, which was composed of 1mg 
azino-di-3-ethylbenzthiazolinsufonic acid (ABTS salt) dissolved in 1ml_ substrate 
buffer (0.1 M sodium citrate, pH 4.5) with sonication in an ultrasound water bath 
for 3 min followed by the addition of hydrogen peroxide (2.5 pL of a 30%  
solution). After 30 min at 37 °C on a rocking platform, the reaction was stopped 
by the addition of 2% aqueous oxalic acid and the plates were read by a 
microplate reader (Bio-Tek Instruments, Inc. VT, USA) at 405 nm.
MALDI-TOF MS Analysis
MALDI- TOF mass spectrometry was performed on a Shimadzu Axima -  
CFR (Manchester, England). The matrix was prepared by dissolving 10 mg a- 
cyano-4-hydroxy cinnamic acid (CHCA) in 1ml_ acetonitrile: water (50:50 v/v). For 
the analysis of GSLs, the matrix was spotted on the MALDI target (1 pL), 
followed by a 1 pL spot of sample dissolved in methanol, and allowed to dry 
before analysis. For the analysis of defensins (MsDefl), 0.5 pL of the sample in 
buffer was mixed with 1.5 pL of matrix and an aliquot of this mixture (1 pL) was 
spotted on the MALDI target and allowed to dry before analysis. All samples 
were analyzed in positive ion mode using the reflector detection mode.
ESI-MS Analysis
Electrospray ionization mass spectrometry was performed on a Finnigan 
LTQ equipped with an Advion Triversa Nanomate ESI chip. GSLs dissolved in 
methanol and defensins in buffer were analyzed in the positive ion mode with a 
spray voltage of 1.4 kV.
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Immunochemistrvfor the MS analysis
Formation of MsDefl-GSL complex for MS analysis was attempted by 
allowing a 1:1 mixture of MsDefl (in buffer) and GSL (in methanol) to stand for a 
period of 2 h at room temperature. For MALDI-MS analysis, the matrix was 
spotted on the MALDI target (1 pL), followed by a 1 pL spot of the reaction 
mixture and allowed to dry before analysis. For ESI-MS analysis, 5 pL of the 
mixture was placed in one well of the 96-well sample plate of the Nanomate ESI 
chip.
Results and Discussion 
After treatment with a strong base and fractionation by anion exchange, 
profiles of crude neutral lipids were compared by HPTLC analysis. Figure 3-2 
shows the TLC profile of crude neutral lipids from the mushroom A. bisporus. 
Previously characterized GlcCer from S. schenckii ar\6 C. neoformans, 
respectively, were used for comparison (represented in lanes S). Lanes 1 and 2 
shows the presence of glucosylceramides in the crude samples.
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Figure 3-2: TLC profile of crude neutral lipid sample fractions detected using 
orcinol. Lanes S = two different GlcCer standards from S. schenckii and C. 
neoformans, respectively, Lanes land 2 = crude neutral lipids (two different 
batches) from A. bisporus.
The purity of GSL samples is very important in binding assay experiments. 
Impurities in the samples can undergo non specific interactions with antibodies 
and give ambiguous results, which could be misleading. To obtain pure GlcCer, 
crude lipid fractions were subjected to purification by column chromatography 
using silica gel as the stationary phase. Figure 3-3 shows the TLC profile (orcinol 
stain) of glucosylceramide fractions from the mushroom A. bisporus separated 
using silica gel as the stationary phase. Lanes 1, 2 and 3 represent consecutive 
fractions eluted by mobile phase solvents F, G> and H, respectively. 
Glucosylceramides along with some impurities, were eluted with solvent G (lane 
2).
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Figure 3-3: TLC analysis of neutral glucosylceramide fractions separated using 
silica gel column chromatography (detected using orcinol). Lanes S = two 
different GlcCer standards from S. schenckii and C. neoformans, respectively, 
Lane 1 = fraction collected in solvent F, Lane 2 = fraction collected in solvent G, 
Lane 3 = fraction collected in solvent H.
Further purification of the solvent G eluted fraction was achieved by column 
chromatography using latrobeads as the stationary phase (these are spherical 
silica gel particles with exceptional uniformity with respect to particle and pore 
size). The same mobile phase solvent systems (F, G, and H) used with the silica 
gel column were employed in latrobeads chromatography. TLC analysis of the 
separated fractions (Figure 3-4) showed that the fraction eluted with solvent G 
(lane 3) now contained pure GlcCer.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 3-4: TLC analysis of the neutral lipid fraction eluted by solvent G, following 
second chromatography on latrobeads column (detected using orcinol). Lane S = 
GlcCer standard, Lane 1 = fraction collected in 100% C H C I 3 ,  Lane 2= fraction 
collected in solvent F, Lane 3 = fraction collected in solvent G, Lane 4 = fraction 
collected in solvent H. Glucosylceramides were eluted with solvent G (lane 3).
Essentially identical protocols were used to purify mono-hexosyl ceramides 
fractions from crude neutral lipids of two other fungal species, Aspergillus 
fumigatus and Neurospora crassa. TLC analysis of purified neutral GlcCer 
fractions from these two fungi, purified using sequential silica gel and latrobeads 
column chromatographies is shown in Figure 3-5A and B.
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Figure 3-5: TLC profile of neutral glucosylceramide fractions from A. fumigatus 
(A) and N. crassa (B) subjected to sequential silica gel and latrobeads column 
chromatography detected using orcinol. Lane S represents the GlcCer standard 
used for comparison. Lanes 1, 2, and 3 represent the fractions eluted from 
latrobeads with mobile phase solvent systems F, G, and H, respectively. 
Glucosylceramides were eluted with solvent G (lane 2).
Previously isolated and purified glucosylceramides of various origins 
were obtained for use as controls with different or identical structural features in 
the binding assay experiments. These are GlcCer from another fungal species F. 
graminearum; and GlcCer of plant origin (extracted from soy beans); GlcCer and 
GalCer of mammalian origin. TLC analysis of all GSLs used in the binding assay 
experiments is shown in Figure 3-6.
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Figure 3-6: TLC analysis of purified neutral monohexosylceramides of various 
origins.
Lane 1 -  A.bisporus -GlcCer
Lane 2 -  A.fumigatus -GlcCer
Lane 3 -  N.crassa -GlcCer
Lane 4 -  F.graminearum -GlcCer
Lane 5 -  Soybean -GlcCer
Lane 6 -  Human -GlcCer
Lane 7 -  Bovine brain -GalCer
Identities and purities of all GSLs used in the study were confirmed using 
MALDI -TOF-MS (spectra shown in Appendix B).
TLC overlay staining with anti-GlcCer
This study was planned as a preliminary step before investigating the 
specific binding of plant defensins to GSLs by TLC immunostaining. The purpose 
of this step was to gain practical knowledge about experimental conditions for 
binding a protein to immobilized GSLs, i.e.,to establish my ability to use
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antibodies against glycolipid antigens in a TLC overlay protocol. In this 
experiment a commercial polyclonal antiserum raised against GlcCer of plant 
origin or human origin, was tested against GlcCer from two different fungi and a 
mammalian GlcCer. TLC images visualized by orcinol and by immunostaining 
are shown in Figure 3-7A and B respectively. It was found that the antiserum 
bound to both of the fungal GlcCer, but showed little detectable binding to 
mammalian GlcCer.
A B
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Figure 3-7: TLC images visualized by orcinol (A) and by immunostaining (B). 
Lanes 1 and 3 represents GlcCer from A.bisporus and A.fumigatus respectively. 
Lane 2 represents GlcCer from Mammalian origin.
TLC overlay staining with plant defensin (M sD efl)
These experiments employed a defensin MsDefl from alfalfa (Medicago 
sativa) which has been shown to have antifungal activity [26]; attempts were
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made to develop an overlay protocol for MsDefl binding using two different 
fungal GlcCer along with mammalian GlcCer on the TLC plate. Various 
experimental conditions were tested in order to observe binding. However, this 
experiment did not give any interpretable results. Regardless of the different 
experimental conditions tried, the defensins appeared to have a nonspecific 
interaction with the silica gel surface of the plate. When the plate was stained 
with the detection antibody and substrate, a dark blue color developed evenly on 
the entire surface of the plate, no matter what GSLs were spotted on it, or where 
the spots were located, and even when no glycolipid was spotted at all. On the 
other hand, when primary antibody, secondary antibody, or MsDefl was left out 
on the protocol, there was no staining at all. We speculate that defensins, which 
are highly basic in nature, might have a high affinity for the acidic sites on the 
silica, and are not removed from the silica surface by normal washing steps, 
which leads to uniform darkening of the plate. Development of an overlay 
protocol for MsDefl binding was therefore abandoned.
Enzyme-Linked ImmunoSorbent Assay (ELISA)
The binding specificity of MsDefl was further analyzed by an ELISA assay 
which should be sensitive in detecting specific antigen-antibody type interactions', 
and does not use an acidic solid surface. GlcCer from four different fungal 
species and plant GlcCer, along with GlcCer and GalCer from mammalian origin, 
were analyzed in the initial experiment (Figure 3-8). Structures of all GlcCer 
employed in this study are shown in Figure 3-9 and 3-10. In this assay, all fungal 
and plant GlcCer showed specific binding to MsDefl in a concentration
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dependent manner. No reactivity was observed with mammalian GlcCer and 
GalCer at any concentrations.
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Figure 3-8: Binding curves showing reactivity of MsDefl with varying 
concentrations of GSLs.
Structural details of the GSLs used in the experiment were compared to 
understand their differences and to shed light on which structural features are 
essential for binding. As shown in Figure 3-10 A and B, there are two types of 
mammalian GalCer, type I, with a 2-hydroxy fatty acid, and type II, which has a 
non-hydroxylated fatty acid. The importance of the hexose moiety in the reactivity 
of MsDefl with GSLs was clearly confirmed from this experiment. A mixture of 
mammalian GalCer type I and II was used in this experiment, and no reactivity 
was observed at any concentrations. The main difference between plant GlcCer 
and mammalian GalCer-l is the hexose moiety (Figure 3-9 C and 3-10 A). Both of 
these GSLs have a saturated 2-hydroxy fatty acid. The fact that plant GlcCer
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shows reactivity and mammalian GalCer-l do not suggests that presence of 
glucose in the GSL structure is the important feature determining the binding 
specificity. The possibility of a 2-hydroxy group on the fatty acid alone being the 
structural determinant in MsDefl recognition is discarded by this result, since 
mammalian GalCer-l presents a 2-hydroxy fatty acid but did not show any 
binding.
Among the various fungal GlcCer employed in the study, GlcCer from 
F.graminearum, A.fumigatus, and N.crassa express ceramides with A3 
unsaturated fatty acids, while A. bisporus has a saturated fatty acyl component 
(Figure 3-9 A and B). Since all fungal GlcCer showed reactivity towards MsDefl 
without any significant differences, it appears that the fatty acyl-A3-unsaturation 
of ceramide does not have any influence on determining the binding specificity. 
Plant GlcCer express ceramide with a saturated 2-hydroxy fatty acid component, 
which is the same as the ceramide in A.bisporus. The main structural difference 
observed between plant and fungal GlcCer is the 9-methyl substituent on the 
sphingoid chain of fungal ceramides, which plants lack (Figure 3-9 B and C).
Both plant and fungal GlcCer spare A8 -unsaturation of the sphingoid. In the 
ELISA assay, both plant and fungal GlcCer showed binding to MsDefl. This 
observation suggests that the 9-methyl substituent on the sphingoid chain of 
ceramide is also not likely to be an important structural feature governing the 
binding.
Mammalian GlcCer shows a number of structural differences from plant 
and fungal GlcCer such as lack of fatty acyl A3-unsaturation, 9-methyl substitution
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on the sphingoid, A8-unsaturation of the sphingoid, and 2-hydroxyl substitution on 
fatty acid. In the ELISA assay, MsDefl reacted effectively with plant GlcCer, 
which has a saturated hydroxylated fatty acyl component, but did not react with 
mammalian GlcCer, which present a saturated non-hydroxylated fatty acid 
(Figure 3-9 C and D). Since the fatty acyl A3-unsaturation and sphingoid 9-methyl 
branch already appear to be non-required features, this result suggests that the
2-hydroxy group of the fatty acid is an important feature governing the MsDefl 
binding to GlcCer. However, another structural difference between mammalian 
and other GlcCer is the A8-unsaturation of the sphingoid, which is present in both 
plants and fungi. From the available results, it is not clear whether this A8- 
unsaturation is involved in the recognition of GlcCer by M sdefl, but we speculate 
that since this structural feature is far away from the main binding epitope it may 
not have any influence in the interaction between MsDefl and GlcCer.
Consistent with this, the 9-methyl substitution on the sphingoid chain, which is 
also far away from the epitope, is not relevant for the binding to occur. Structural 
features such as 9-methyl substitution and A8-unsaturation of the sphingosine are 
likely to be embedded in the cell membrane, and presumably do not have 
significant effects on binding specificity. From these results it was concluded that 
the minimum epitope required for optimum binding of MsDefl with GlcCer would 
comprise the presence of a (3-D-glucose residue and the 2-hydroxy group of the 
fatty acid. Other structural variations observed do not appear to have any 
relevance governing binding specificity of MsDefl with GlcCer.
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Figure 3-9: Various GlcCer showing structural variations in the ceramide moiety.
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Figure 3-10: Mammalian GalCer types I and II showing structural variations in the 
ceramide moiety. Type I has 2-hydroxy fatty acid.
Another ELISA experiment was conducted employing another defensin 
named MtDef4, which is also from Medicago spp. and has shown strong 
antifungal activity. MtDef4 shares 41% identity in amino acid sequences with 
MsDefl [38, 39]. Even though defensins vary greatly in their amino acid 
composition, they all have a compact shape that is stabilized by either four or five 
intramolecular disulfide bonds. In this experiment the binding specificity of 
MtDef4 with GlcCerfrom N.crassa and plant origin, along with mammalian 
GlcCer and GalCer, were compared. As a positive control, MsDefl was also
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used with the same set of GSLs, Resulting binding curves are shown in Figure 3-
11 .
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Figure 3-11: Binding curves showing reactivity of MsDefl and MtDef4 with 
varying concentrations of GSLs
As expected, MsDefl showed specific binding to N.crassa and plant GlcCer 
in a concentration dependent manner, and did not react with mammalian GlcCer 
and GalCer. However, MtDef4 did not react with any of the GSLs at any 
concentration. From this observation we can suggest that the antifungal activity 
of MtDef4 is probably not be based on interaction with GlcCer or GalCer. At this 
point we do not have any information on whether any components of the cell 
membrane have a role in MtDef4 recognition. The mode of antifungal action of 
MtDef4 will need to be established by further research.
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MALDI-TOF MS Analysis
The molecular mass and expected disulfide bridging of the defensin 
(M sD efl) preparation we are using was confirmed by MALDI-MS analysis. The 
monoisotopic singly charged parent ion mass of M sD efl, calculated from the 
complete amino acid sequence, is 5192.2469 Da. The calculated average 
molecular mass for MsDefl is 5195.8815 Da. In the theoretical isotope 
distribution, the m/z of the tallest peak is also predicted to be at m/z 5195. 
However, MsDefl has eight cysteine residues and forms four disulfide bridges in 
its native folded state. Therefore, in the folded state, the monoisotopic mass of 
MsDefl is predicted to be 5184.1845 Da, and the average molar mass is 
predicted to be 5187.8175 Da (with the loss of eight hydrogens while forming four 
disulfide bridges). Figure 3-12 shows the MALDI-MS profile obtained for MsDefl; 
an isotope cluster with the tallest peak was observed at m/z 5187. This is 
consistent with the average molecular mass of MsDefl with all four disulfide 
bonds intact.
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Figure 3-12: MALDI -MS of MsDefl showing the singly charged molecular ion of 
average mass 5187 Da.
When a mixture of MsDefl and GlcCer from N. crassa was subjected to 
MALDI - MS analysis no significant peaks were detected in the anticipated region 
of the mass spectrum. Mixtures of MsDefl and GlcCer in varying concentrations 
were analyzed with two different matrices (a-cyano-4-hydroxy cinnamic acid and 
dihydroxybenzoic acid). W e speculate that the complex molecules could not be 
preserved and detected due to the energy impact during the ionization process 
with the matrices and experimental conditions employed. Excess salt on the 
target surface, resulting from the dried buffer, could also interfere with detection. 
These experimental conditions could perhaps be optimized to enable the 
detection of the MsDefl - GlcCer complex.
It is worth noting that MALDI has been much less frequently applied to 
study non-covalent complexes. The sample preparation process for MALDI, that
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is, crystallizing the analyte with a large molar excess of organic chromophore, 
could to be denaturing for many proteins, so that only the most stable non- 
covalent complexes could be preserved and ultimately detected. The co­
crystallization step includes complex physical and chemical processes involving 
interactions of the analyte with matrix molecules in solution and after 
crystallization. Many attempts have been made to detect intact complexes using 
MALDI; however, no significant trends can be drawn for a general protocol on the 
target preparation process [44, 45, 46]. Thus the failure to detect a non-covalent 
complex ion in a MALDI spectrum does not necessarily allow conclusions to be 
drawn regarding hypothesized interactions.
ESI - MS Analysis
Electrospray ionization has long been recognized as the method of choice 
for studying non-covalent antibody-peptide complexes [47]. ESI experiments cart 
be carried out using aqueous solutions containing volatile buffers to maintain 
physiological pH, ionic strength, or other conditions that preserve the integrity of 
the complex in solution. Ion generation from a solution is quite natural for protein 
complexes, and particular conditions have been found to preserve the weak 
protein associations. In addition, electrostatic and dipolar interactions are 
strengthened in the absence of solvent, allowing the generation and detection of 
very large intact complex ions [48, 50]. Noncovalent complexes between proteins 
and lipids have also been studied successfully. The advantages of ESI-MS also 
include high selectivity and sensitivity along with speed of analysis. A variety of 
protocols has been devised to validate specificity of interactions [47].
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Figure 3-13 shows ESI-MS spectra of MsDefl and GlcGerfrom N.crassa 
(Panels A and B, respectively). Triply and quadruply charged ions, ([M+3H]3+ 
and [M+4H]4+), for MsDefl were observed at m/z 1729 and 1297 respectively 
(Figure 3-13 A); doubly charged ion (predicted at m/z 2593) is beyond the m/z 
range of the instrument. As expected the GlcCer fraction from N. crassa showed 
a sodiated molecular ion profile with the most abundant peak at m/z 776 and a 
much less abundant peak at m/z 778 (overlapped with M+2 isotope peak for m/z 
776) [30, 34]. These are consistent with [M + N a]+ adducts of GlcCer containing 
two ceramide types, each having a d18:2 sphingoid chain, with h i8:1 and h18:0 
fatty acid respectively (Figure 3-13 B). It appears from this spectrum that the A3- 
unsaturated fatty acid form is greatly predominant in this GlcCer fraction.
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Figure 3-13: ESI-MS of MsDefl in buffer (A) showing the [M+3H]3+ and 
[M+4H]4+ molecular ions at m/z 1729 and 1297 respectively (A) and the 
[M + Na] + adduct of GlcCer from N.crassa (B)
Analysis of a solution containing a 1:1 mixture of MsDefl and GlcCer 
showed an isotopic cluster with the tallest peak at m/z 1485, as shown in Figure
3-14. A quadruply charged MsDefl-GlcCer complex ion, [M+4H]4+, is predicted 
to be at m/z 1486, which is consistent with the observed peak. If the complex 
were detected as a fully sodiated adduct, the [M+4Na]4+, it is predicted to appear
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at m/z 1508. However, it is an unlikely form for what is mainly protein. Further 
experiments will need to be carried out to characterize the MsDefl-GlcCer 
complex observed at m/z 1486. A low energy CID- MS2 analysis could possibly 
reveal whether the species observed at m/z 1486 includes a bound GlcCer. Less 
abundant peaks of non-bound MsDefl at m/z 1297 ([M+4H]4+) and GlcCer at 
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Figure 3-14: ESI-MS of MsDefl -  GlcCer mixture showing the abundant ion at 
m/z 1486.
Some analytes tend to form non-covalent gas phase assemblies, despite 
the nonexistence of the corresponding complexes in solution. The role MS plays 
in characterizing noncovalent complexes is entirely complimentary to other 
techniques, but can still be useful [47]. The fact that different types of
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intermolecular forces appear to be of different relative importance in maintaining 
complexes in the gas and solution phases suggest that their comparison can 
provide important insights into the nature of the interaction between a protein and 
its ligands.
Conclusion and Future work 
It should be noted that in this project only preliminary experiments were 
conducted to detect a bimolecular complex by mass spectrometry. At this point, it 
appears that we have been successful, but many additional experiments could 
be performed to reach the initial goal of characterizing the complex. Once 
detected, considerable work remains to verify that it is specific and meaningful. A 
low energy CID- MS2 analysis of the complex should reveal whether the species 
observed includes a bound GlcCer. It would also be of considerable interest to 
see if the pattern of recognition of GSL structural variations by M sD efl, as 
observed in the ELISA experiments, could be recapitulated by differential 
detection of complexes in ESI-MS. For example, would the observation that 
MsDefl recognized fungal and plant GlcCer, but did not bind to mammalian 
GlcCer and GalCer, be repeatable using MS methods. Other more established 
techniques, such as crystallography and NMR, could also be tried to provide 
more details into the possible structure of a bimolecular MsDefl-GlcCer complex.
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APPENDIX A
DOWNFIELD SECTIONS OF 1H -  13C gHSQC NMR SPECTRA OF MIPC AND
M(IP)2C
















APPENDIX A CONTINUED  
1H -  13C aHSQC -  M(IP)?C
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MALDI -  MS SPECTRA OF GSLs USED IN ELISA Experiments 
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APPENDIX B CONTINUED
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APPENDIX B CONTINUED 
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APPENDIX B CONTINUED
GlcCer from plant origin (soybean)
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